Healthcare provider profile · identity verified

Douglas J Federman, M.D.

Internal Medicine · TOLEDO, OH · NPI 1427043629

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	535	144
Amlodipine Besylate	Amlodipine Besylate	433	113
Lisinopril	Lisinopril	218	66
Levothyroxine Sodium	Levothyroxine Sodium	204	49
Pantoprazole Sodium	Pantoprazole Sodium	200	57
Metformin Hcl	Metformin Hcl	199	49
Hydrochlorothiazide	Hydrochlorothiazide	169	49
Gabapentin	Gabapentin	165	34
Metoprolol Succinate	Metoprolol Succinate	152	46
Tamsulosin Hcl	Tamsulosin Hcl	140	40
Spironolactone	Spironolactone	134	33
Metoprolol Tartrate	Metoprolol Tartrate	114	27
Omeprazole	Omeprazole	111	31
Albuterol Sulfate Hfa	Albuterol Sulfate	106	29
Furosemide	Furosemide	104	31
Sertraline Hcl	Sertraline Hcl	104	21
Fluticasone Propionate	Fluticasone Propionate	97	29
Trulicity	Dulaglutide	92	17
Losartan Potassium	Losartan Potassium	86	29
Alendronate Sodium	Alendronate Sodium	82	16
Famotidine	Famotidine	79	15
Carvedilol	Carvedilol	78	25
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	76	20
Valsartan	Valsartan	70	18
Clopidogrel	Clopidogrel Bisulfate	67	20
Fluoxetine Hcl	Fluoxetine Hcl	66	suppressed
Metformin Hcl Er	Metformin Hcl	65	19
Potassium Chloride	Potassium Chloride	65	20
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	64	15
Alprazolam	Alprazolam	58	15
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	58	13
Baclofen	Baclofen	57	11
Allopurinol	Allopurinol	52	16
Meloxicam	Meloxicam	51	12
Trazodone Hcl	Trazodone Hcl	51	15
Risperidone	Risperidone	48	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	47	12
Rosuvastatin Calcium	Rosuvastatin Calcium	46	17
Celecoxib	Celecoxib	44	11
Simvastatin	Simvastatin	44	13
Donepezil Hcl	Donepezil Hcl	43	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	43	14
Eliquis	Apixaban	41	14
Synthroid	Levothyroxine Sodium	41	11
Zolpidem Tartrate	Zolpidem Tartrate	41	12
Oxybutynin Chloride Er	Oxybutynin Chloride	39	suppressed
Pregabalin	Pregabalin	39	suppressed
Ammonium Lactate	Ammonium Lactate	38	suppressed
Montelukast Sodium	Montelukast Sodium	37	suppressed
Pravastatin Sodium	Pravastatin Sodium	37	12
Lansoprazole	Lansoprazole	36	suppressed
Clonazepam	Clonazepam	35	suppressed
Chlorthalidone	Chlorthalidone	32	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	32	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	32	11
Mirtazapine	Mirtazapine	32	suppressed
Buspirone Hcl	Buspirone Hcl	31	suppressed
Tizanidine Hcl	Tizanidine Hcl	31	13
Doxazosin Mesylate	Doxazosin Mesylate	29	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	29	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	28	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	26	suppressed
Warfarin Sodium	Warfarin Sodium	26	suppressed
Finasteride	Finasteride	25	11
Lorazepam	Lorazepam	24	suppressed
Nystop	Nystatin	24	suppressed
Ezetimibe	Ezetimibe	23	suppressed
Glimepiride	Glimepiride	23	suppressed
Topiramate	Topiramate	23	suppressed
Farxiga	Dapagliflozin Propanediol	22	suppressed
Januvia	Sitagliptin Phosphate	22	suppressed
Olanzapine	Olanzapine	22	suppressed
Tramadol Hcl	Tramadol Hcl	22	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	21	suppressed
Levetiracetam	Levetiracetam	20	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	20	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Clonidine Hcl	Clonidine Hcl	19	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Hydrocortisone	Hydrocortisone	19	suppressed
Ibuprofen	Ibuprofen	19	suppressed
Ozempic	Semaglutide	19	suppressed
Prednisone	Prednisone	19	suppressed
Aripiprazole	Aripiprazole	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Meclizine Hcl	Meclizine Hcl	18	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	suppressed
Azithromycin	Azithromycin	16	suppressed
Nystatin	Nystatin	16	suppressed
Oxycodone Hcl	Oxycodone Hcl	16	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Duloxetine Hcl	Duloxetine Hcl	14	suppressed
Primidone	Primidone	14	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	14	suppressed
Bumetanide	Bumetanide	13	suppressed
Desmopressin Acetate	Desmopressin Acetate	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	13	suppressed
Midodrine Hcl	Midodrine Hcl	13	suppressed
Oxcarbazepine	Oxcarbazepine	13	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Cilostazol	Cilostazol	12	suppressed
Diazepam	Diazepam	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Propylthiouracil	Propylthiouracil	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Atenolol	Atenolol	11	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	11	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	11	suppressed
Fenofibrate	Fenofibrate,micronized	11	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Jardiance	Empagliflozin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error